Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease

Clinical trial NCT06531798 · RECRUITING

Trial details

NCT number: NCT06531798
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Moderate to Severe COPD

Start date: 2026-01-30
Primary completion: 2026-10-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.